Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- Relistor (methylnaltrexone)
- selpercatinib
Interactions between your drugs
methylnaltrexone selpercatinib
Applies to: Relistor (methylnaltrexone), selpercatinib
Information for this minor interaction is available on the professional version.
Drug and food interactions
selpercatinib food
Applies to: selpercatinib
You should limit or avoid consumption of grapefruit and grapefruit juice during treatment with selpercatinib unless directed otherwise by your doctor. Grapefruit juice may increase the blood levels of selpercatinib. High levels of selpercatinib can increase the risk of an irregular heart rhythm that may be serious and potentially life-threatening, although it is a relatively rare side effect. You may be more susceptible if you have a heart condition called congenital long QT syndrome, other cardiac diseases, conduction abnormalities, or electrolyte disturbances (for example, magnesium or potassium loss due to severe or prolonged diarrhea or vomiting). The risk and/or severity of other side effects may also increase, including nausea, vomiting, constipation, diarrhea, rash, muscle and joint pain, swelling of arms or legs, liver problems, high blood pressure, and bleeding complications. Talk to your doctor if you experience intolerable or troublesome side effects, or you have other questions or concerns. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with selpercatinib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
methylnaltrexone food
Applies to: Relistor (methylnaltrexone)
Food may reduce the absorption of methylnaltrexone when taken orally, which may lead to lower blood levels of the medication and possibly reduced effectiveness. You should take oral preparations of methylnaltrexone on an empty stomach at least 30 minutes before your first meal of the day.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Amitiza
Amitiza (lubiprostone) is used to treat chronic constipation and irritable bowel syndrome with ...
GoLYTELY
GoLYTELY is used for bowel preparation, constipation, chronic, gastrointestinal decontamination
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Movantik
Movantik reduces constipation caused by opioid pain medicine used to treat severe chronic pain. It ...
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
GaviLyte-G
GaviLyte-G is used for bowel preparation, constipation, chronic, gastrointestinal decontamination
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
PEG-3350 with Electolytes
PEG-3350 with Electolytes is used for bowel preparation, constipation, chronic, gastrointestinal ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.